BRCA1 Versus BRCA2 and PARP Inhibitor Sensitivity in Prostate Cancer: More Different Than Alike?

J Clin Oncol. 2020 Nov 10;38(32):3735-3739. doi: 10.1200/JCO.20.02246. Epub 2020 Sep 1.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • BRCA1 Protein / genetics
  • BRCA2 Protein / genetics
  • Genes, BRCA2
  • Humans
  • Indoles / therapeutic use
  • Male
  • Poly(ADP-ribose) Polymerase Inhibitors* / therapeutic use
  • Prostatic Neoplasms, Castration-Resistant* / drug therapy

Substances

  • BRCA1 Protein
  • BRCA1 protein, human
  • BRCA2 Protein
  • BRCA2 protein, human
  • Indoles
  • Poly(ADP-ribose) Polymerase Inhibitors
  • rucaparib